Skip to main content
Clinical Trials/DRKS00015843
DRKS00015843
Recruiting
Not Applicable

Collection of samples for the development and validation of analytical methods in Clinical Pharmacology (KPE37) - KPE37

ehrstuhl für Klinische Pharmakologie und Klinische Toxikologie der Friedrich-Alexander-Universität Erlangen-Nürnberg0 sites120 target enrollmentDecember 12, 2018

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
ehrstuhl für Klinische Pharmakologie und Klinische Toxikologie der Friedrich-Alexander-Universität Erlangen-Nürnberg
Enrollment
120
Status
Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 12, 2018
End Date
TBD
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ehrstuhl für Klinische Pharmakologie und Klinische Toxikologie der Friedrich-Alexander-Universität Erlangen-Nürnberg

Eligibility Criteria

Inclusion Criteria

  • written informed consent

Exclusion Criteria

  • medical contraindication against the planned type of sample collection, clinical relevant anemia, clinical relevant abnormalities of the urinary tract, clinical relevant abnormalities of the mouth or the salivary glands, acute diseases, pregnant or breast\-feeding women, employees of the department of Clinical Pharmacology at the Friedrich\-Alexander\-Universität Erlangen\-Nürnberg, students still having to take exams at the department of Clinical Pharmacology (especially students studying medicine, dentistry, molecular medicine, pharmacy or medical process management)

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Sample collection for an assay development to determine HSV-specific T-cell responses in blood samples from HSV-2 infected individuals and HSV-1 + HSV-2 infected individualsgenital herpesoral herpesB00Herpesviral [herpes simplex] infections
DRKS00031143Heidelberg ImmunoTherapeutics GmbH29
Recruiting
Not Applicable
Sample Collection Study for Scientific Evaluation of Laboratory Interference of CyFlow Antibodies for Flow CytometrySample Collection Study for Scientific Evaluation of Laboratory Interference of CyFlow™ Antibodies for Flow Cytometry
DRKS00033260PSHI Praxis GmbH65
Not yet recruiting
Not Applicable
Prospective sample collection, data collection and analysis for the clinical applicability of immunome profiles in the discrimination and therapy monitoring of COVID-19 patients in different disease stages as well as for the identification and characterization of long-term consequences of a SARS-CoV-2 infection in comparison to patients with a respiratory non-COVID-19 viral infectious disease and healthy controls.U07.1COVID-19, virus identified
DRKS00024422Fraunhofer ITMP200
Completed
Not Applicable
Prospective collection of data and biomaterial of COVID-19 at the location WürzburgU07.1COVID-19, virus identified
DRKS00022402niversitätsklinikum Würzburg94
Completed
Not Applicable
Registration and sample collection for identification of genetic and public health characteristics of the major birth defects in koreaCongenital malformations, deformations and chromosomal abnormalities
KCT0003671Korea Centers for Disease Control and Prevention1,400